Enveda
Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.
$311MSeries E
ParticipantDV
Digitalis Ventures
Activity from announced rounds
All recorded activity
- Rounds participated in
- 3
- Confirmed lead rounds
- 0 2 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $438M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in all activityClasp
Connects healthcare employers with clinicians, tying student loan repayment to tenure
$20MSeries B
Role not disclosedEpiBiologics
Develops bispecific antibodies for targeted degradation of extracellular proteins.
$107MSeries B
Role not disclosed